In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain

Diagnostic Microbiology and Infectious Disease
Cristina SeralF Javier Castillo

Abstract

In vitro cefditoren antimicrobial activity was tested against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in our hospital from January 2005 to May 2006 by agar dilution and broth microdilution method, respectively. MICs were also determined for 13 and 10 comparison drugs, respectively. The pneumococci tested comprised 113 (39.2%) penicillin susceptible, 91 (31.6%) penicillin intermediate, and 84 (29.2%) penicillin resistant. Cefditoren was the most active drug on the basis of the MICs (MIC(90)=0.5 microg/mL), followed by ceftriaxone and levofloxacin (MIC(90)=1 microg/mL). Cefditoren MICs ranged from 0.25 to 1 microg/mL for ceftriaxone-resistant isolates, with a modal MIC of 0.5 microg/mL and an MIC(90) of 1.0 microg/mL. No S. pneumoniae isolates evaluated in this study showed MICs to cefditoren higher than 1 microg/mL (MIC range, <or=0.015 to 1 microg/mL). Against penicillin-resistant pneumococci, the rank order of intrinsic activity (MIC(90), microg/mL) was cefditoren (0.5)<ceftriaxone (2.0)=cefotaxime (2.0)<amoxicillin/clavulanate (8.0)=amoxicillin (8.0)=cefuroxime (8.0). Among the 220 strains of H. influenzae, 42 (19.09%) produced a beta-lactamase (Hi beta+) and 3 (1.1%) were beta-la...Continue Reading

References

Sep 1, 1991·Diagnostic Microbiology and Infectious Disease·N X ChinH C Neu
Sep 1, 1988·Antimicrobial Agents and Chemotherapy·A TamuraS Mitsuhashi
Nov 18, 1998·The Journal of Antimicrobial Chemotherapy·E SakagawaT Ou
Nov 1, 2001·Diagnostic Microbiology and Infectious Disease·R N JonesP C Fuchs
Feb 1, 2002·Diagnostic Microbiology and Infectious Disease·James A KarlowskyDaniel F Sahm
Jul 4, 2002·The Journal of Antimicrobial Chemotherapy·Catherine L ClarkPeter C Appelbaum
Jan 31, 2003·The Journal of Antimicrobial Chemotherapy·J García-De-LomasC Gimeno
Apr 28, 2005·Antimicrobial Agents and Chemotherapy·Emilio Pérez-TralleroUNKNOWN Spanish Surveillance Group for Respiratory Pathogens
Jun 17, 2006·International Journal of Antimicrobial Agents·Mi Young LeeJae-Hoon Song

❮ Previous
Next ❯

Citations

Jun 8, 2012·International Journal of General Medicine·José BarberánMaría-José Giménez
Jul 23, 2009·Journal of Chemotherapy·M L MezzatestaG Nicoletti
Aug 25, 2009·Kansenshōgaku zasshi. The Journal of the Japanese Association for Infectious Diseases·Eri HagiwaraHiroshi Takahashi
Oct 15, 2010·International Journal of Immunopathology and Pharmacology·G TemperaG Nicoletti
Nov 10, 2018·Multidisciplinary Respiratory Medicine·María-José GiménezJuan José Granizo
Jan 10, 2021·Antibiotics·Elena Lia SpoialăCristina Gavrilovici

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.